Oncostatin M Receptor–Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
Anjali Geethadevi(Medical College of Wisconsin), Pradeep Chaluvally–Raghavan(Medical College of Wisconsin)
Cited by 71
Related Papers
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer
|npj Precision Oncology|2024|13
RNA-binding protein FXR1 drives cMYC translation by mRNA circularization through eIF4F recruitment in ovarian cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0